Birth Control News and Research

RSS

Birth control pills may reduce woman's bone density

Birth control pills may reduce a woman's bone density, according to a study published online July 13 in The Journal of Clinical Endocrinology and Metabolism by Group Health Research Institute (GHRI) scientists.

20 Jul 2011

First Edition: July 19, 2011

Kaiser Health News staff writer Christopher Weaver reports: "New consumer-controlled health insurance plans could get seed money from the government to increase competition - and maybe cut prices -- under new rules announced Monday by the Department of Health and Human Services".

19 Jul 2011

CLEOPATRA Phase III study on HER2-positive mBC meets primary endpoint

Genentech, a member of the Roche Group, today announced that CLEOPATRA, a pivotal Phase III study, met its primary endpoint.

15 Jul 2011

Novartis Afinitor Phase III trial on tuberous sclerosis meets primary endpoint

Novartis Pharmaceuticals Corporation announced today Phase III trial results that showed more than one-third of patients taking Afinitor tablets experienced a 50% or greater reduction in the size of their subependymal giant cell astrocytomas, non-cancerous brain tumors associated with tuberous sclerosis complex.

8 Jul 2011

N.C. Gov. Vetoes abortion bill; 2 Kansas doctors file suit against Kansas law; R.I. exchange bill caught in dispute

Gov. Bev Perdue vetoed a bill Monday that would require women seeking abortions to wait 24 hours after state-prescribed counseling, leaving the bill's House supporters looking for override votes. The bill would have made significant changes in state abortion policy, changes supporters said would give pregnant women important information about fetal development and abortion alternatives.

30 Jun 2011

FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer

Genentech, a member of the Roche Group, announced today that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA's Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin in combination with paclitaxel chemotherapy for previously untreated HER2-negative metastatic breast cancer.

30 Jun 2011

Abortion policies under scrutiny in a number of states

Wisconsin's governor signed a budget that cuts some funds to health clinics, including Planned Parenthood, but in Indiana, a federal judge ruled against the state's plans to end funding for the group. Those developments came as abortion policies are coming under scrutiny in a number of states.

27 Jun 2011

Longer looks: Turning doctors' views of alternative therapies; a male birth control pill; teenagers and tanning beds

Medicine has long decried acupuncture, homeopathy, and the like as dangerous nonsense that preys on the gullible. Again and again, carefully controlled studies have shown alternative medicine to work no better than a placebo. But now many doctors admit that alternative medicine often seems to do a better job of making patients well, and at a much lower cost, than mainstream care — and they're trying to learn from it.

18 Jun 2011

Roundup: Few states raise taxes to ease budgets; Ala. Gov. signs abortion law; Texas House advances bill to turn Medicaid, Medicare into block grants

As 2011 began, the budget situation in state capitals looked more dire than just about anybody could remember. ... With Medicaid, the states had their hands tied. The new federal health care law prohibits states from cutting eligibility or making it harder for people to apply for coverage. So states had to find other ways to control costs. Idaho reduced the amount paid to hospitals and doctors to treat Medicaid patients, an idea that some 30 governors proposed this year.

17 Jun 2011

First Edition: June 10, 2011

Today's health policy headlines include reports about health law funding and policy particulars, as well as Dems' push to protect Medicaid.

10 Jun 2011

Less-invasive Pro-Vas occlusion shows promise for permanent male sterilization

A new clinical study presented at the American Urological Association (AUA) Annual Meeting shows the less-invasive Pro-Vas occlusion as a highly promising method of permanent male sterilization.

9 Jun 2011

Estrogen therapy improves low bone density in teenage girls with anorexia nervosa

Estrogen therapy improves low bone density due to anorexia nervosa in teenage girls with the disease when given as a patch or as a low oral dose that is physiological.

6 Jun 2011

Genentech's Avastin, chemotherapy Phase III combination study data on ovarian cancer presented at ASCO

Genentech, a member of the Roche Group, today announced results from OCEANS, a Phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.

6 Jun 2011

Safety of birth control pills under scrutiny

Bayer’s oral contraceptive pills are being reviewed by regulators after some studies suggested they may cause more blood clots than competing medicines.

5 Jun 2011

Indiana officials say they will defy federal order on Planned Parenthood

State lawyers say they must obey a law signed by the governor last month that bars funding to clinics offering abortions. Medicaid officials warned this week that denying payments for covered health services was illegal and could endanger all federal Medicaid payments to the state.

4 Jun 2011

First Edition: June 3, 2011

Reporting for Kaiser Health News, Marilyn Chase writes: "Memorial, a 278-bed hospital in this city 55 miles north of San Francisco, sued California to try to stop the payment reductions. Now it is part of a case before the U.S. Supreme Court that could redefine states' responsibilities on Medicaid services and ultimately determine whether Democratic Gov. Jerry Brown can go forward with cuts he says are vital to closing the state's budget gap.

3 Jun 2011

Birth control pill safety issues raised

The U.S. Food and Drug Administration (FDA) has announced that it is looking at results from two studies that showed there is a higher risk of blood clots in women taking new birth control pills containing the compound drospirenone. Some brand names include Yaz, Yasmin, Beyaz, Ocella, Loryna, Gianvi, Safyral, Syeda and Zarah.

1 Jun 2011

Senate Democrats pressure states to maintain funding for Planned Parenthood

Some Democratic senators are asking a top government health official to warn states that if they try to exclude family planning clinics like Planned Parenthood from Medicaid and Title X funding, they'll face penalties from the federal government (5/27).

27 May 2011

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has approved INCIVEK™ (telaprevir) tablets for a broad group of people with genotype 1 chronic hepatitis C with compensated liver disease (some level of damage to the liver but the liver still functions), including cirrhosis (scarring of the liver).

23 May 2011

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.

20 May 2011